Wharton, Sean http://orcid.org/0000-0003-0111-1530
Astrup, Arne http://orcid.org/0000-0001-8968-8996
Endahl, Lars
Lean, Michael E. J. http://orcid.org/0000-0003-2216-0083
Satylganova, Altynai
Skovgaard, Dorthe
Wadden, Thomas A.
Wilding, John P. H. http://orcid.org/0000-0003-2839-8404
Article History
Received: 15 July 2020
Revised: 3 November 2020
Accepted: 15 December 2020
First Online: 18 January 2021
Compliance with ethical standards
:
: SW: advisory boards and honoraria for academic talks from Bausch Health, Eli Lilly, Janssen, and Novo Nordisk. Department grants for research and obesity treatment from Novo Nordisk. Research Grants from CIHR and MITACS. AA: consultant or member of advisory boards for a number of companies, including BioCare, Dutch Beer Institute, Gelesis, Groupe Éthique et Santé, McCain Foods Limited, Novo Nordisk A/S, Ritual Inc., Saniona, and WW (formerly Weight Watchers). LE: employee of, and holds shares in, Novo Nordisk A/S. MEJL: departmental grants for obesity treatment from Novo Nordisk. Advisory boards and lecturing fees from Eli Lilly, Novo Nordisk, Roche, and Sanofi. Research grants from Diabetes UK. Expenses for scientific meetings from American Diabetes Association, Diabetes UK, and European Association for the Study of Diabetes Nutrition Study Group. AS: employee of, and holds shares in, Novo Nordisk A/S. DCS: employee of Novo Nordisk A/S. TAW: serves on advisory boards for Novo Nordisk and WW (formerly Weight Watchers) and has received grant support, on behalf of the University of Pennsylvania, from Novo Nordisk. JPHW: outside the submitted work, has grants, personal fees for lectures and consultancy fees (paid to his institution) from AstraZeneca and Novo Nordisk; personal fees for lectures and consultancy fees (paid to his institution) from Boehringer Ingelheim, Eli Lilly, Janssen, Mundipharma, Napp, Sanofi, and Takeda; and consultancy fees (paid to his institution) from Rhythm Pharmaceuticals and Wilmington Healthcare.